Verapamil Hydrochloride Extended-Release tablets — Class III drug recall D1834-2015
Terminated recall by Apotex Inc., reported 2015-10-07, distributed nationwide. Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification li
| Recall number | D1834-2015 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Apotex Inc., Toronto, Ontario, Canada |
| Recall initiated | 2015-07-21 |
| Classified | 2015-09-30 |
| Reported by FDA | 2015-10-07 |
| Terminated | 2017-02-15 |
| Distributed | Nationwide (US) |
| Quantity | 2,075 bottles |
| Reason classes | specification failure |
| NDC | 60505-2742-05 |
| Lot numbers | KP2621 |
| Expiration dates | 2015-08 |
Product
Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp. Manufactured by Apotex Research Private Limited, Bangalore, Karnataka 560 099, India; Manufactured for: Apotex Corp., Weston, FL 33326. NDC 60505-2742-5.
Reason for recall
Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D1834-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.